Effect of Citicoline on Neurological Severity Score and Cerebral Doppler Resistive Index in Neonatal Hypoxic Ischemic Encephalopathy: A Randomized Control Trial

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-24
SponsorKhyber Girls Medical College

About this trial

To determine the efficacy of citicoline in improving cerebral blood flow parameters and neurological status among neonates with hypoxic-ischemic encephalopathy using Doppler resistive index and Sarnat-Sarnat score after 72 hours of therapy.

Eligibility criteria

Qualifiers

All inborn neonates diagnosed with APGAR score (Table 2) less then 8/10 at 5 min of life presenting to the emergency room within the first day of life.

Outborn babies admitted in the last 24 hours with history or clinical features of perinatal asphyxia.

Disqualifiers

Neonates who have received therapeutic hypothermia

Neonates with congenital, developmental or chromosomal malformations

Significant antenatal risk factors leading to early-onset sepsis\DIC or CNS depression unrelated to asphyxia

Preterm neonates <35 weeks

Trial design

Treatments tested in this trial

  • Citicoline
  • Standard medical treatment

Treatment groups

86 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Khyber Girls Medical College

Lead sponsor

Hayatabad Medical Complex

Collaborator